DEAR DR. ROACH: Would it be possible for you to explain my recent diagnosis of monoclonal gammopathy of uncertain significance (MGUS)? Apparently, 3% to 5% of the population over the age of 50 show ...

Speakers on precursor disease addressed distinctions between MGUS and smoldering multiple myeloma, risk stratification, and new thinking on the role of immunological aging, especially how it affects ...

As a part of its “Speaking Out” video series, on behalf of the International Myeloma Foundation, CURE® spoke with their chief medical officer, Dr. Joseph Mikhael about the precursors to multiple ...

The global Monoclonal Gammopathy of Undetermined Significance (MGUS) Management Market is poised for robust growth, rising ...

A new research perspective was published in Oncotarget's Volume 15 on January 16, 2024, entitled, “Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma.” Multiple ...

A plasma cell neoplasia is a benign or malignant disease defined by the overproduction of plasma cells. The three types of plasma cell neoplasms include monoclonal gammopathy of undetermined ...

Share on Pinterest Researchers continue to study the risk factors for the blood cancer multiple myeloma. Abraham Gonzalez Fernandez/Getty Images Smoking, poor sleep, and obesity may increase the risk ...

GLP-1RAs were associated with lower risk for major adverse cardiovascular and cerebrovascular events in MGUS with type 2 diabetes.

Dear Dr. Roach: Would it be possible for you to explain my recent diagnosis of monoclonal gammopathy of uncertain significance (MGUS)? Apparently, 3% to 5% of the population over the age of 50 show ...